Literature DB >> 9490286

A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb.

M Okubo1, A Horinishi, N Nakamura, Y Aoyama, M Hashimoto, Y Endo, T Murase.   

Abstract

Genetic deficiency of the glycogen-debranching enzyme (debrancher) causes glycogen storage disease type III (GSD III), which is divided into two subtypes: IIIa and IIIb. In GSD IIIb, glycogen accumulates only in the liver, whereas both liver and muscles are involved in GSD IIIa. The molecular basis for the differences between the two subtypes has not been fully elucidated. Recently, mutations in exon 3 of the debrancher gene were reported to be specifically associated with GSD IIIb. However, we describe a homozygous GSD IIIb patient without mutations in exon 3. Analysis of the patient's debrancher cDNA revealed an 11-bp insertion in the normal sequence. An A to G transition at position -12 upstream of the 3' splice site of intron 32 (IVS 32 A-12-->G) was identified in the patient's debrancher gene. No mutations were found in exon 3. Mutational analysis of the family showed the patient to be homozygous for this novel mutation as well as three polymorphic markers. Furthermore, the mother was heterozygous and the parents were first cousins. The acceptor splice site mutation created a new 3' splice site and resulted in insertion of an 11-bp intron sequence between exon 32 and exon 33 in the patient's debrancher mRNA. The predicted mutant enzyme was truncated by 112 amino acids as a result of premature termination. These findings suggested that a novel IVS 32 A-12-->G mutation caused GSD IIIb in this patient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490286     DOI: 10.1007/s004390050646

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of the molecular basis of glycogen storage disease type III.

Authors:  T Fukuda; H Sugie; M Ito
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

2.  Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.

Authors:  Yoriko Endo; Asako Horinishi; Matthias Vorgerd; Yoshiko Aoyama; Tetsu Ebara; Toshio Murase; Masato Odawara; Teodor Podskarbi; Yoon S Shin; Minoru Okubo
Journal:  J Hum Genet       Date:  2006-09-19       Impact factor: 3.172

3.  Glycogen storage disease type III in the Irish population.

Authors:  Ellen Crushell; Eileen P Treacy; J Dawe; M Durkie; Nicholas J Beauchamp
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

4.  Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.

Authors:  Christiaan P Sentner; Yvonne J Vos; Klary N Niezen-Koning; Bart Mol; G Peter A Smit
Journal:  JIMD Rep       Date:  2012-03-16

5.  Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.

Authors:  Ili Syazwana Abdullah; Ser-Huy Teh; Fiqri Dizar Khaidizar; Lock-Hock Ngu; Wee-Teik Keng; Sufin Yap; Zulqarnain Mohamed
Journal:  Genes Genomics       Date:  2019-04-26       Impact factor: 1.839

6.  Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.

Authors:  Yoriko Endo; Ekram Fateen; Yoshiko Aoyama; Asako Horinishi; Tetsu Ebara; Toshio Murase; Yoon S Shin; Minoru Okubo
Journal:  J Hum Genet       Date:  2005-09-28       Impact factor: 3.172

7.  Different clinical aspects of debrancher deficiency myopathy.

Authors:  S Kiechl; U Kohlendorfer; C Thaler; D Skladal; M Jaksch; B Obermaier-Kusser; J Willeit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 8.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

9.  Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.

Authors:  Faten Ben Rhouma; Hatem Azzouz; François M Petit; Mariem Ben Khelifa; Amel Ben Chehida; Fehmi Nasrallah; Frédéric Parisot; Khaled Lasram; Rym Kefi; Yosra Bouyacoub; Lilia Romdhane; Christiane Baussan; Naziha Kaabachi; Marie-Françoise Ben Dridi; Neji Tebib; Sonia Abdelhak
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

10.  SINE indel polymorphism of AGL gene and association with growth and carcass traits in Landrace x Jeju Black pig F(2) population.

Authors:  Sang-Hyun Han; Kwang-Yun Shin; Sung-Soo Lee; Moon-Suck Ko; Dong Kee Jeong; Hong-Shik Oh; Byoung-Chul Yang; In-Cheol Cho
Journal:  Mol Biol Rep       Date:  2009-08-01       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.